These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38752538)

  • 1. Inhibition of NLRP3 inflammasome by MCC950 under hypoxia alleviates photoreceptor apoptosis via inducing autophagy in Müller glia.
    Gao S; Li N; Lin Z; Zhong Y; Wang Y; Shen X
    FASEB J; 2024 May; 38(10):e23671. PubMed ID: 38752538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Geranylgeranyl diphosphate synthase 1 knockdown suppresses NLRP3 inflammasome activity via promoting autophagy in sepsis-induced acute lung injury.
    Li D; Li C; Wang T; Zhang C; Zhu Z; Zhang G; Fang B
    Int Immunopharmacol; 2021 Nov; 100():108106. PubMed ID: 34530204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of NLRP3 inflammasome ameliorates LPS-induced neuroinflammatory injury in mice via PINK1/Parkin pathway.
    Wang A; Zhong G; Ying M; Fang Z; Chen Y; Wang H; Wang C; Liu C; Guo Y
    Neuropharmacology; 2024 Oct; 257():110063. PubMed ID: 38972372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MCC950 Reduces Neuronal Apoptosis in Spinal Cord Injury in Mice.
    He N; Zheng X; He T; Shen G; Wang K; Hu J; Zheng M; Ding Y; Song X; Zhong J; Chen YY; Wang LL; Yueliang S
    CNS Neurol Disord Drug Targets; 2021 Oct; 20(3):298-308. PubMed ID: 33023460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective NLRP3 inflammasome inhibitor reduces neuroinflammation and improves long-term neurological outcomes in a murine model of traumatic brain injury.
    Xu X; Yin D; Ren H; Gao W; Li F; Sun D; Wu Y; Zhou S; Lyu L; Yang M; Xiong J; Han L; Jiang R; Zhang J
    Neurobiol Dis; 2018 Sep; 117():15-27. PubMed ID: 29859317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of NLRP3 inflammasome by MCC950 improves the metabolic outcome of islet transplantation by suppressing IL-1β and islet cellular death.
    Matsuoka T; Yoshimatsu G; Sakata N; Kawakami R; Tanaka T; Yamada T; Yoshida Y; Hasegawa S; Kodama S
    Sci Rep; 2020 Oct; 10(1):17920. PubMed ID: 33087823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NLRP3 Inflammasome Inhibition by MCC950 in Aged Mice Improves Health via Enhanced Autophagy and PPARα Activity.
    Marín-Aguilar F; Castejón-Vega B; Alcocer-Gómez E; Lendines-Cordero D; Cooper MA; de la Cruz P; Andújar-Pulido E; Pérez-Alegre M; Muntané J; Pérez-Pulido AJ; Ryffel B; Robertson AAB; Ruiz-Cabello J; Bullón P; Cordero MD
    J Gerontol A Biol Sci Med Sci; 2020 Jul; 75(8):1457-1464. PubMed ID: 31603987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of NLRP3 inflammasome alleviates cognitive deficits in a mouse model of anti-NMDAR encephalitis induced by active immunization.
    Yang X; Sun A; Kong L; Yang X; Zhao X; Wang S
    Int Immunopharmacol; 2024 Aug; 137():112374. PubMed ID: 38851162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MCC950, a selective NLPR3 inflammasome inhibitor, improves neurologic function and survival after cardiac arrest and resuscitation.
    Jiang M; Li R; Lyu J; Li X; Wang W; Wang Z; Sheng H; Zhang W; Karhausen J; Yang W
    J Neuroinflammation; 2020 Aug; 17(1):256. PubMed ID: 32867797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the NLRP3 inflammasome reduces brain edema and regulates the distribution of aquaporin-4 after cerebral ischaemia-reperfusion.
    Wang H; Chen H; Jin J; Liu Q; Zhong D; Li G
    Life Sci; 2020 Jun; 251():117638. PubMed ID: 32251636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of NLRP3 inflammasome inhibition by MCC950 on LPS-induced pancreatic adenocarcinoma inflammation.
    Yaw ACK; Chan EWL; Yap JKY; Mai CW
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2219-2229. PubMed ID: 32507974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MCC950 Inhibits NLRP3 Inflammasome and Alleviates Axonal Injures in Early Stages of Diffuse Axonal Injury in Rats.
    Zhao J; Guo X; Wang B; Yang Z; Huang T; Guo D; Zhang M; Song J
    Neurochem Res; 2020 Sep; 45(9):2020-2031. PubMed ID: 32474832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibiting the NLRP3 inflammasome with MCC950 ameliorates retinal neovascularization and leakage by reversing the IL-1β/IL-18 activation pattern in an oxygen-induced ischemic retinopathy mouse model.
    Sui A; Chen X; Shen J; Demetriades AM; Yao Y; Yao Y; Zhu Y; Shen X; Xie B
    Cell Death Dis; 2020 Oct; 11(10):901. PubMed ID: 33093455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MCC950 attenuates doxorubicin-induced myocardial injury in vivo and in vitro by inhibiting NLRP3-mediated pyroptosis.
    Zhang L; Jiang YH; Fan C; Zhang Q; Jiang YH; Li Y; Xue YT
    Biomed Pharmacother; 2021 Nov; 143():112133. PubMed ID: 34474337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel complementary coloprotective effects of metformin and MCC950 by modulating HSP90/NLRP3 interaction and inducing autophagy in rats.
    Saber S; El-Kader EMA
    Inflammopharmacology; 2021 Feb; 29(1):237-251. PubMed ID: 32594364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the NLRP3 Inflammasome With Inhibitor MCC950 Prevents Aortic Aneurysms and Dissections in Mice.
    Ren P; Wu D; Appel R; Zhang L; Zhang C; Luo W; Robertson AAB; Cooper MA; Coselli JS; Milewicz DM; Shen YH; LeMaire SA
    J Am Heart Assoc; 2020 Apr; 9(7):e014044. PubMed ID: 32223388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy.
    Wu M; Yang Z; Zhang C; Shi Y; Han W; Song S; Mu L; Du C; Shi Y
    Metabolism; 2021 May; 118():154748. PubMed ID: 33675822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E-Deficient Mice-Brief Report.
    van der Heijden T; Kritikou E; Venema W; van Duijn J; van Santbrink PJ; Slütter B; Foks AC; Bot I; Kuiper J
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1457-1461. PubMed ID: 28596375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyroptosis inhibitors MCC950 and VX-765 mitigate myocardial injury by alleviating oxidative stress, inflammation, and apoptosis in acute myocardial hypoxia.
    Ye X; Lin ZJ; Hong GH; Wang ZM; Dou RT; Lin JY; Xie JH; Shen YW
    Exp Cell Res; 2024 May; 438(2):114061. PubMed ID: 38692345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockage of the NLRP3 inflammasome by MCC950 inhibits migration and invasion in adenomyosis.
    Liu Y; Jiang Z; Zhang L; Tian W; Lin A; Li M
    Reprod Biomed Online; 2024 Oct; 49(4):104319. PubMed ID: 39121559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.